• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconNovartis

Novartis

Page 4 of 5
Close up of surgical tools and money
HealthTwo of the World’s Best-Selling Drugs Are Headed for a Lot More Competition
By Sy MukherjeeJuly 15, 2016
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Shares of Next-Gen Cancer Biotech Juno Rallied Today
By Sy MukherjeeJuly 13, 2016
Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself
HealthWhy a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself
By Sy MukherjeeJune 27, 2016
Pharmacy technician Andrea Tibbetts counts out pills to fill an order for generic medications at Por
HealthThis Is the Most Important Business Trend in Pharma
By Sy MukherjeeJune 21, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthThese Are the Most Promising Experimental Cancer Drugs
By Sy MukherjeeJune 9, 2016
The Sad and Inspiring Reason This Top Novartis Exec Stepped Down
MPWThe Sad and Inspiring Reason This Top Novartis Exec Stepped Down
By Eileen DaspinMay 31, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
HealthStruggling Novartis Heart Drug Boosted by New Medical Guidelines
By ReutersMay 21, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
HealthNovartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthWatchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By ReutersMarch 31, 2016
Venezuela Tense As Unrest Over President Maduro's Government Continues
Venezuela Is Using Distressed Bonds to Pay Off Its Debts to Drugmakers
By ReutersMarch 7, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
FinanceNovartis Agrees to $390 Million Settlement
By Jen WiecznerNovember 20, 2015
Parkinson’s patients show improvement after taking cancer drug
HealthParkinson’s patients show improvement after taking cancer drug
By Claire ZillmanOctober 19, 2015
France's Gevrise Emane (L) celebrates he
Leadership40 Under 40: Advice I’d give my 20-year-old self
By Daniel RobertsSeptember 25, 2015
40 Under 40: The lowest moment in my career
Leadership40 Under 40: The lowest moment in my career
By Jonathan ChewSeptember 25, 2015
Novartis’s pathway to business longevity
FeaturesNovartis’s pathway to business longevity
By Geoff ColvinMarch 21, 2013
1
  • 1
  • 2
  • 3
  • 4
  • 5
5
Most Popular
Economy
The U.S. government is spending $88 billion a month in interest on national debt—equal to spending on defense and education combinedplaceholder alt text
By Fortune EditorsApril 9, 2026
AI
A Meta employee created a dashboard so coworkers can compete to be the company's No. 1 AI token user—and Zuckerberg doesn't even rank in the top 250placeholder alt text
By Fortune EditorsApril 9, 2026
Success
Gen Z doesn't want your full-time job. They want several part-time roles, and it's reshaping the entire workforceplaceholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.